➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Medtronic
Boehringer Ingelheim
Colorcon

Last Updated: May 17, 2021

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca AB v. Aurobindo Pharma Ltd. (D. Del. 2014)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in AstraZeneca AB v. Aurobindo Pharma Ltd.
The small molecule drugs covered by the patents cited in this case are   Get Started Free ,   Get Started Free ,   Get Started Free , and   Get Started Free .

Details for AstraZeneca AB v. Aurobindo Pharma Ltd. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-05-23 1 product, prior to expiration of U.S. Patent No. 7,951,400 (“the ’400 patent”). … This is an action for patent infringement arising under the patent laws of the United States, … THE ’400 PATENT 14. On May 31, 2011, the U.S. Patent and Trademark Office …copy of the ’400 patent is attached hereto as Exhibit A. The claims of the ’400 patent are valid and …includes ONGLYZA® together with the’400 patent and U.S. Patent No. RE44,186, which covers the composition External link to document
2015-02-17 138 Infringement and Invalidity Contentions for U.S. Patent Nos. 7,951,400 and 8,628,799 by Actavis Laboratories FL…2014 2 February 2017 1:14-cv-00664 830 Patent Defendant District Court, D. Delaware External link to document
2015-04-13 155 Dismissal of Formulation Patent Claims Concerning U.S. Patent No. 7,951,400 Between AstraZeneca and Aurobindo…2014 2 February 2017 1:14-cv-00664 830 Patent Defendant District Court, D. Delaware External link to document
2015-04-13 160 CLAIMS AND COUNTERCLAIMS CONCERNINGU.S. PATENT NOS. 7,951,400 AND 8,628,799 filed by AstraZeneca AB. Signed…2014 2 February 2017 1:14-cv-00664 830 Patent Defendant District Court, D. Delaware External link to document
2015-04-13 161 Stipulation of Dismissal of Formulation Patent Claims U.S. Patent Nos. 7,951,400 AND 8,628,799 filed by AstraZeneca…2014 2 February 2017 1:14-cv-00664 830 Patent Defendant District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Dow
McKesson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.